Zoetis to Acquire Neogen’s Animal Genomics Business

Today, Neogen Corporation, an innovative leader in food safety solutions, announced it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc., the world’s leading animal health company, for $160 million, subject to customary closing adjustments.

Neogen’s planned divestiture, which had been previously announced, was part of the company’s portfolio review strategy to simplify the business and focus on core strategic markets.

“Neogen’s genomics business (GeneSeek) has been a pioneer in advanced DNA testing for livestock and has set a high standard for innovation across the livestock sector, with globally recognized solutions spanning genomic prediction, herd improvement and data integration,” says Tom Schultz, Neogen head of commercial global genomics."We’re excited to build on that foundation in our future with Zoetis and to continue advancing tools that strengthen animal health, performance and overall profitability. Customers can expect a thoughtful transition and continued excellent service,”

Click here to contniue reading

By Angie Stump Denton

March 2, 2026